4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BGM Group Ltd. (BGM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chengdu, China. Its market capitalization is roughly $125 million. In the fiscal year ended 2024-09-30, BGM reported $25M in revenue and ($1M) in net income.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China.
Interactive charts & full statements →
| Income statement | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
| Total Revenue | $25M | $46M | $65M | $57M |
| Gross Profit | $4M | $2M | $6M | $6M |
| Operating Income (EBIT) | ($0M) | ($2M) | $2M | $3M |
| Net Income | ($1M) | ($8M) | $1M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
| Dividends Paid | $0M | ($2M) | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
| Total Assets | $53M | $51M | $64M | $75M |
| Total Liabilities | $9M | $7M | $10M | $19M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BGM viewer.
About TickerBase · Data methodology & sources